KEY INSIGHTS
External partnerships in veterinary research driving veterinary vaccine development
External partnerships and strategic collaborations between companies and the academia are expected to drive R&D and the revenue growth of the veterinary vaccine market. For example, veterinary vaccine manufacturer Zoetis revealed that through two collaborative research projects funded by the 6th and 7th EU Framework Programs, Suvaxyn CSF Marker, a potent new live marker in veterinary vaccines for Classic Swine Fever (CSF), was developed, validated and finally approved by EMA in February 2015.

Source: Click here